Pharmacy

Your Article Summary

See Latest Articles

Iloperidone (Fanapt): Psychotropic agent approved for the acute treatment of schizophrenia
Formulary , 06/08/09

The mechanism of action of iloperidone, a psychotropic agent, is unknown, but researchers have proposed that the agent's efficacy is mediated through antagonism of dopamine type 2 (D2) and serotonin type 2 (5-HT2). This agent was approved on May 2009, for the acute treatment of adult patients with schizophrenia.

Today in Drug Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/22/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09

See All of Drug Approvals

Today in Drug/Product Alerts...keeping you current

Receive free subspecialty "5-minute updates" via email

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09

Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Archives of Neurology, 11/23/09

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 11/02/09

See All of Drug/Product Alerts

Today in Neuro/Psych pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Outcome of intracerebral haemorrhage patients pre-treated with statins
European Journal of Neurology, 11/17/09

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09

Statin use and neurologic morbidity after coronary artery bypass grafting. A cohort study
Neurology, 11/16/09

See All of Neuro/Psych pharmacology